DE60214533D1 - Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen - Google Patents

Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen

Info

Publication number: DE60214533D1
Authority: DE; Germany
Prior art keywords: pyridoindolon; derivatives; containing pharmaceutical; antibodies containing; pharmaceutical mixtures
Prior art date: 2001-04-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60214533T

Other languages

English (en)

Other versions

DE60214533T2 (de

Inventor

Bernard Bourrie

Pierre Casellas

Jean-Marie Derocq

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis France

Original Assignee

Sanofi Aventis France

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-27

Filing date

2002-04-26

Publication date

2006-10-19

2002-04-26 Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France

2006-10-19 Application granted granted Critical

2006-10-19 Publication of DE60214533D1 publication Critical patent/DE60214533D1/de

2007-06-21 Publication of DE60214533T2 publication Critical patent/DE60214533T2/de

2022-04-27 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DE60214533T 2001-04-27 2002-04-26 Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen Expired - Lifetime DE60214533T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0105843		2001-04-27
FR0105843A FR2823975B1 (fr)	2001-04-27	2001-04-27	Nouvelle utilisation de pyridoindolone
PCT/FR2002/001450 WO2002087575A1 (fr)	2001-04-27	2002-04-26	Associations pharmaceutiques a base de derives de pyridoindolone et d'agents anticancereux

Publications (2)

Publication Number	Publication Date
DE60214533D1 true DE60214533D1 (de)	2006-10-19
DE60214533T2 DE60214533T2 (de)	2007-06-21

Family

ID=8862882

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE60214533T Expired - Lifetime DE60214533T2 (de)	2001-04-27	2002-04-26	Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen
DE60208365T Expired - Lifetime DE60208365T2 (de)	2001-04-27	2002-04-26	Verwendung von pyridoindolonderivaten zur herstellung von antikrebsmitteln

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE60208365T Expired - Lifetime DE60208365T2 (de)	2001-04-27	2002-04-26	Verwendung von pyridoindolonderivaten zur herstellung von antikrebsmitteln

Country Status (34)

Country	Link
US (3)	US6967203B2 (de)
EP (2)	EP1385512B1 (de)
JP (2)	JP2004528343A (de)
KR (1)	KR100847413B1 (de)
CN (2)	CN1505511A (de)
AR (1)	AR034313A1 (de)
AT (2)	ATE314070T1 (de)
BG (2)	BG108260A (de)
BR (1)	BR0209138A (de)
CA (2)	CA2443012C (de)
CY (1)	CY1105813T1 (de)
CZ (2)	CZ299465B6 (de)
DE (2)	DE60214533T2 (de)
DK (2)	DK1385512T3 (de)
EA (1)	EA005930B1 (de)
EE (2)	EE200300466A (de)
ES (2)	ES2271264T3 (de)
FR (1)	FR2823975B1 (de)
HK (2)	HK1059895A1 (de)
HU (2)	HUP0400744A2 (de)
IL (4)	IL158312A0 (de)
IS (1)	IS2441B (de)
MX (1)	MXPA03009639A (de)
NO (2)	NO20034787L (de)
NZ (1)	NZ528671A (de)
PL (2)	PL366910A1 (de)
PT (2)	PT1385512E (de)
RS (2)	RS50791B (de)
RU (1)	RU2292888C9 (de)
SK (2)	SK13252003A3 (de)
TW (1)	TWI252104B (de)
UA (1)	UA74876C2 (de)
WO (2)	WO2002087574A2 (de)
ZA (1)	ZA200307785B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2823975B1 (fr) *	2001-04-27	2003-05-30	Sanofi Synthelabo	Nouvelle utilisation de pyridoindolone
US7456193B2 (en)	2002-10-23	2008-11-25	Sanofi-Aventis	Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2846329B1 (fr)	2002-10-23	2004-12-03	Sanofi Synthelabo	Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2869316B1 (fr) *	2004-04-21	2006-06-02	Sanofi Synthelabo	Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) *	2005-10-20	2008-06-27	Sanofi Aventis Sa	Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1268772A (en) *	1968-03-15	1972-03-29	Glaxo Lab Ltd	NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) *	1978-06-05	1981-04-21	Sumitomo Chemical Company, Limited	7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) *	1979-07-10	1981-05-30	Ленинградский Химико-Фармацевтическийинститут	Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
SU833972A1 (ru)	1979-10-26	1981-05-30	Институт Физико-Органической Химиии Углехимии Ah Украинской Ccp	Имидазо(4,5-с)пиридиний иодиды вКАчЕСТВЕ пРОМЕжуТОчНыХ пРОдуКТОВ дл СиНТЕзА фуНгицидОВ
FR2595701B1 (fr) *	1986-03-17	1988-07-01	Sanofi Sa	Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
US5035252A (en) *	1990-12-14	1991-07-30	Mondre Steven J	Nicotine-containing dental floss
DE69535703T2 (de) *	1994-04-13	2009-02-19	The Rockefeller University	AAV-vermittelte Zufuhr von DNA an Zellen des Nervensystems
DE19502753A1 (de) *	1995-01-23	1996-07-25	Schering Ag	Neue 9H-Pyrido[3,4-b]indol-Derivate
US6486177B2 (en) *	1995-12-04	2002-11-26	Celgene Corporation	Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
FR2765581B1 (fr) *	1997-07-03	1999-08-06	Synthelabo	Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
FR2765582B1 (fr) *	1997-07-03	1999-08-06	Synthelabo	Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
AU3375999A (en) *	1998-04-02	1999-10-25	Neurogen Corporation	Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino(2,3-b)indole and 5,6,7,8-tetrahydro-9h-pyrimidino(4,5-b)indole derivatives: crf1 specific ligands
IT1313592B1 (it)	1999-08-03	2002-09-09	Novuspharma Spa	Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) *	2001-03-30	2002-10-24	Gerald Minuk	Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) *	2001-04-27	2003-05-30	Sanofi Synthelabo	Nouvelle utilisation de pyridoindolone
FR2846329B1 (fr)	2002-10-23	2004-12-03	Sanofi Synthelabo	Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2846330B1 (fr)	2002-10-23	2004-12-03	Sanofi Synthelabo	Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
US6958347B2 (en)	2002-12-18	2005-10-25	Pfizer Inc.	Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists
FR2869316B1 (fr)	2004-04-21	2006-06-02	Sanofi Synthelabo	Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr)	2005-10-20	2008-06-27	Sanofi Aventis Sa	Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

2001
- 2001-04-27 FR FR0105843A patent/FR2823975B1/fr not_active Expired - Fee Related
2002
- 2002-04-26 EE EEP200300466A patent/EE200300466A/xx unknown
- 2002-04-26 WO PCT/FR2002/001449 patent/WO2002087574A2/fr active IP Right Grant
- 2002-04-26 CZ CZ20032910A patent/CZ299465B6/cs not_active IP Right Cessation
- 2002-04-26 EP EP02732841A patent/EP1385512B1/de not_active Expired - Lifetime
- 2002-04-26 DE DE60214533T patent/DE60214533T2/de not_active Expired - Lifetime
- 2002-04-26 CA CA002443012A patent/CA2443012C/fr not_active Expired - Fee Related
- 2002-04-26 RU RU2003130376/15A patent/RU2292888C9/ru active
- 2002-04-26 SK SK1325-2003A patent/SK13252003A3/sk unknown
- 2002-04-26 ES ES02735502T patent/ES2271264T3/es not_active Expired - Lifetime
- 2002-04-26 IL IL15831202A patent/IL158312A0/xx unknown
- 2002-04-26 PL PL02366910A patent/PL366910A1/xx unknown
- 2002-04-26 KR KR1020037013925A patent/KR100847413B1/ko not_active IP Right Cessation
- 2002-04-26 PT PT02732841T patent/PT1385512E/pt unknown
- 2002-04-26 CA CA002444334A patent/CA2444334A1/fr not_active Abandoned
- 2002-04-26 WO PCT/FR2002/001450 patent/WO2002087575A1/fr active IP Right Grant
- 2002-04-26 HU HU0400744A patent/HUP0400744A2/hu unknown
- 2002-04-26 IL IL15826602A patent/IL158266A0/xx unknown
- 2002-04-26 UA UA2003109248A patent/UA74876C2/uk unknown
- 2002-04-26 EP EP02735502A patent/EP1385513B1/de not_active Expired - Lifetime
- 2002-04-26 AR ARP020101521A patent/AR034313A1/es unknown
- 2002-04-26 EA EA200301062A patent/EA005930B1/ru not_active IP Right Cessation
- 2002-04-26 DK DK02732841T patent/DK1385512T3/da active
- 2002-04-26 CN CNA028089596A patent/CN1505511A/zh active Pending
- 2002-04-26 ES ES02732841T patent/ES2254683T3/es not_active Expired - Lifetime
- 2002-04-26 CZ CZ20032909A patent/CZ295224B6/cs not_active IP Right Cessation
- 2002-04-26 SK SK1324-2003A patent/SK13242003A3/sk unknown
- 2002-04-26 NZ NZ528671A patent/NZ528671A/en unknown
- 2002-04-26 US US10/476,322 patent/US6967203B2/en not_active Expired - Lifetime
- 2002-04-26 PT PT02735502T patent/PT1385513E/pt unknown
- 2002-04-26 CN CNB028088980A patent/CN1240382C/zh not_active Expired - Fee Related
- 2002-04-26 MX MXPA03009639A patent/MXPA03009639A/es active IP Right Grant
- 2002-04-26 HU HU0400745A patent/HUP0400745A2/hu unknown
- 2002-04-26 TW TW091108716A patent/TWI252104B/zh not_active IP Right Cessation
- 2002-04-26 JP JP2002584919A patent/JP2004528343A/ja active Pending
- 2002-04-26 EE EEP200300465A patent/EE200300465A/xx unknown
- 2002-04-26 AT AT02732841T patent/ATE314070T1/de not_active IP Right Cessation
- 2002-04-26 BR BR0209138-0A patent/BR0209138A/pt not_active IP Right Cessation
- 2002-04-26 AT AT02735502T patent/ATE338548T1/de not_active IP Right Cessation
- 2002-04-26 JP JP2002584920A patent/JP2004531538A/ja active Pending
- 2002-04-26 RS YUP-839/03A patent/RS50791B/sr unknown
- 2002-04-26 DK DK02735502T patent/DK1385513T3/da active
- 2002-04-26 DE DE60208365T patent/DE60208365T2/de not_active Expired - Lifetime
- 2002-04-26 PL PL02366916A patent/PL366916A1/xx not_active IP Right Cessation
- 2002-04-26 US US10/476,321 patent/US7524857B2/en active Active
- 2002-04-26 RS YUP-834/03A patent/RS50790B/sr unknown
2003
- 2003-10-02 IL IL158266A patent/IL158266A/en not_active IP Right Cessation
- 2003-10-06 ZA ZA200307785A patent/ZA200307785B/en unknown
- 2003-10-08 IL IL158312A patent/IL158312A/en not_active IP Right Cessation
- 2003-10-09 IS IS6984A patent/IS2441B/is unknown
- 2003-10-13 BG BG108260A patent/BG108260A/bg unknown
- 2003-10-13 BG BG108261A patent/BG108261A/bg unknown
- 2003-10-24 NO NO20034787A patent/NO20034787L/no not_active Application Discontinuation
- 2003-10-24 NO NO20034785A patent/NO20034785L/no not_active Application Discontinuation
2004
- 2004-04-20 HK HK04102775A patent/HK1059895A1/xx not_active IP Right Cessation
- 2004-05-03 HK HK04103103A patent/HK1060066A1/xx not_active IP Right Cessation
2005
- 2005-08-15 US US11/204,275 patent/US7160895B2/en not_active Expired - Lifetime
2006
- 2006-11-30 CY CY20061101725T patent/CY1105813T1/el unknown

Also Published As

Publication number	Publication date
RU2003130376A (ru)	2005-04-10
NO20034787L (no)	2003-12-23
HK1060066A1 (en)	2004-07-30
CZ295224B6 (cs)	2005-06-15
IL158312A (en)	2009-09-01
ES2271264T3 (es)	2007-04-16
CA2444334A1 (fr)	2002-11-07
EP1385512A2 (de)	2004-02-04
WO2002087574A3 (fr)	2003-02-13
US7160895B2 (en)	2007-01-09
PL366910A1 (en)	2005-02-07
CZ20032909A3 (en)	2004-06-16
CY1105813T1 (el)	2011-02-02
HUP0400744A2 (hu)	2004-06-28
CN1505511A (zh)	2004-06-16
CN1505510A (zh)	2004-06-16
DE60214533T2 (de)	2007-06-21
IL158266A (en)	2009-09-01
US6967203B2 (en)	2005-11-22
YU83903A (sh)	2006-08-17
BG108260A (bg)	2004-12-30
HK1059895A1 (en)	2004-07-23
US7524857B2 (en)	2009-04-28
HUP0400745A2 (hu)	2004-08-30
EE200300466A (et)	2003-12-15
UA74876C2 (en)	2006-02-15
ATE314070T1 (de)	2006-01-15
SK13242003A3 (sk)	2004-03-02
DK1385513T3 (da)	2007-01-15
IL158312A0 (en)	2004-05-12
NO20034785L (no)	2003-12-23
RU2292888C9 (ru)	2007-06-20
EP1385513A1 (de)	2004-02-04
EP1385512B1 (de)	2005-12-28
KR20040015138A (ko)	2004-02-18
CA2443012A1 (en)	2002-11-07
ZA200307785B (en)	2004-10-06
KR100847413B1 (ko)	2008-07-18
DE60208365T2 (de)	2006-09-07
IS6984A (is)	2003-10-09
US20050272760A1 (en)	2005-12-08
FR2823975A1 (fr)	2002-10-31
YU83403A (sh)	2006-08-17
DK1385512T3 (da)	2006-05-22
EP1385513B1 (de)	2006-09-06
DE60208365D1 (de)	2006-02-02
IL158266A0 (en)	2004-05-12
NZ528671A (en)	2004-06-25
NO20034785D0 (no)	2003-10-24
EA200301062A1 (ru)	2004-04-29
JP2004531538A (ja)	2004-10-14
IS2441B (is)	2008-11-15
CN1240382C (zh)	2006-02-08
CA2443012C (fr)	2009-07-28
CZ20032910A3 (en)	2004-07-14
TWI252104B (en)	2006-04-01
WO2002087574A2 (fr)	2002-11-07
SK13252003A3 (sk)	2004-03-02
WO2002087575A1 (fr)	2002-11-07
ATE338548T1 (de)	2006-09-15
BG108261A (bg)	2004-12-30
EE200300465A (et)	2003-12-15
MXPA03009639A (es)	2004-06-30
RS50791B (sr)	2010-08-31
US20040122027A1 (en)	2004-06-24
NO20034787D0 (no)	2003-10-24
US20040122036A1 (en)	2004-06-24
RS50790B (sr)	2010-08-31
BR0209138A (pt)	2004-06-08
PT1385513E (pt)	2007-01-31
AR034313A1 (es)	2004-02-18
CZ299465B6 (cs)	2008-08-06
RU2292888C2 (ru)	2007-02-10
PL366916A1 (en)	2005-02-07
ES2254683T3 (es)	2006-06-16
JP2004528343A (ja)	2004-09-16
EA005930B1 (ru)	2005-08-25
FR2823975B1 (fr)	2003-05-30
PT1385512E (pt)	2006-05-31

Legal Events

Date	Code	Title	Description
2007-09-27	8364	No opposition during term of opposition

Publication	Publication Date	Title
CY2016022I2 (el)	2016-10-05	Παραγωγο 2-οξο-1-πυρρολιδινης και οι φαρμακευτικες του χρησεις
ATE404180T1 (de)	2008-08-15	Geschmacksmaskierte pharmazeutische partikel
DE60029115D1 (de)	2006-08-10	Antigen enthaltende pharmazeutische zusammensetzung
NO20033556D0 (no)	2003-08-11	Farmasöytiske preparater
ATE307571T1 (de)	2005-11-15	Pharmazeutische formulierung enthaltend bicalutamid
ATE317260T1 (de)	2006-02-15	Pharmazeutische formulierungen mit platinderivaten
CY2014008I2 (el)	2015-12-09	Παραγωγα κιναζολινης, φαρμακα που περιεχουν τις ενωσεις αυτες, χρηση αυτων και μεθοδους για την παραγωγη τους
DE60201988D1 (de)	2004-12-23	Pharmazeutische dosierungsform von amorphem nilfenavir mesylat
NO20071303L (no)	2001-07-27	Farmasoytiske preparater
NO20044192L (no)	2004-10-04	17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
DK1400518T3 (da)	2007-03-26	Heterocycliske forbindelser og lægemidler
DE60127002D1 (de)	2007-04-12	Pharmazeutische zusammensetzung
NO20020464L (no)	2002-03-20	Flerkomponents farmasöytisk doseringsform
NO20033384D0 (no)	2003-07-29	Farmasöytisk formulering
DE60213592D1 (de)	2006-09-14	Flüssige pharmazeutische zusammensetzung
DE60201859D1 (de)	2004-12-16	Pharmazeutische Verwendung von N-Carbamoylazol-Derivate
EE200300311A (et)	2003-10-15	Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
DE60037816D1 (de)	2008-03-06	Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
DE50206476D1 (de)	2006-05-24	Cyanoanthranylamid-derivate und deren verwendung als arzneimittel
ATE350016T1 (de)	2007-01-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
DE60129238D1 (de)	2007-08-16	Pharmazeutische zusammensetzung
ATE434435T1 (de)	2009-07-15	Pharmazeutische zubereitungen enthaltend modafinil
DE60232445D1 (de)	2009-07-09	Cetirizin und pseudoephedrin enthaltende tablette
EE200300135A (et)	2003-08-15	Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid
DE60214533D1 (de)	2006-10-19	Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen